Related Experiment Video
Updated: May 5, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
34.4K
Alpha-1 antitrypsin in childhood asthma.
The Journal of Allergy and Clinical Immunology
|January 1, 1977
Summary
Alpha-1 antitrypsin (AAT) levels were higher in mild childhood asthma patients compared to severe cases. This suggests AAT variants are not strongly linked to asthma severity, but inflammation may affect AAT levels.
Area of Science:
- Pulmonology
- Genetics
- Biochemistry
Background:
- Childhood perennial asthma is a significant respiratory condition.
- Alpha-1 antitrypsin (AAT) is a proteinase inhibitor with potential roles in inflammatory diseases.
- Understanding AAT's role in asthma severity is crucial for treatment strategies.
Purpose of the Study:
- To investigate Alpha-1 antitrypsin (AAT) phenotypes and serum levels in two distinct childhood perennial asthma populations.
- To determine if specific AAT variants are associated with asthma severity.
- To explore the relationship between AAT serum levels and asthma severity, including steroid dependence.
Main Methods:
- Studied AAT phenotypes and serum levels in mild, non-steroid-dependent asthmatic children and severe, steroid-dependent asthmatic children.
- Compared AAT prevalences and serum levels between the two asthmatic groups and a non-asthmatic control group.
- Analyzed Alpha-1 antitrypsin protease inhibitor (Pi) types.
Main Results:
- AAT phenotypes were similarly distributed across both mild and severe asthma groups, mirroring general population frequencies.
- Mild, non-steroid-dependent asthmatic children exhibited significantly elevated AAT serum levels compared to the severe, steroid-dependent group.
- The severe, steroid-dependent asthma group showed AAT serum levels comparable to non-asthmatic children.
Conclusions:
- Findings suggest that common AAT variants (e.g., Pi MZ, Pi MS) are not strongly associated with increased childhood asthma severity.
- Elevated AAT serum levels in milder asthma may reflect chronic inflammatory processes.
- Normal AAT levels in severe asthma could be influenced by corticosteroid treatment controlling inflammation.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.2K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.2K
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:28Asthma I: Introduction
311
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311
01:13Asthma III: Clinical Manifestations
73
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73